Xconomy | Seattle - Business + Technology in the Exponential Economy

Geospiza to Acquire VizX Labs’ Genesifter Technology For Genomic Data
Back from Vacation, Technology Alliance’s Susannah Malarkey Delivers the Goods On Startups
Geospiza Cuts Deal With Illumina, To Help Scientists Cope With Information Overload
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News
Agios, Developer of Drugs That Starve Cancer Cells, Scarfs Up $33 Million in Venture Funds

Geospiza Sells Genetics Software To Harvard Medical, Children’s Hospital Boston

Geospiza, a Seattle-based maker of software to help researchers analyze reams of genomic data, said today it has sold its FinchLab product to the Molecular Genetics Core Facility shared by Children’s Hospital Boston and Harvard Medical School. Terms of the transaction weren’t disclosed, although Geospiza president Rob Arnold said it June that it typically charges $30,000 for software, or about $2,500 a month.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can email him at ltimmerman@xconomy.com or call 206-624-2374.

Comments | Permalink |